Drug · DIN 02324652
PRO-SUMATRIPTAN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 1, 2026; first marketed June 15, 2009.
- Drug Identification Number (DIN)
- 02324652
- Company (DIN owner)
- Pro Doc LimiteeLaval, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- September 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 1, 2026: NOC 38209Supplement to an Abbreviated New Drug Submission (SANDS) · Administrative: Change in product name Administrative: Update to labelling (to match Licensor)
- August 2, 2016: NOC 18323Supplement to an Abbreviated New Drug Submission (SANDS) · Product monograph update to match the innovator's product monograph
- June 9, 2009: NOC 10244Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named PRO-SUMATRIPTAN
- DIN 02324660 · Marketed